Fox Run Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLD
BBA
KCM
Fox Run Management's PRLD Position: Q3 2026 in Review
Fox Run Management opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 23,226 shares worth $90.8K. The stake represents 0.01% of the portfolio and ranks #914 among its holdings.
90 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.
- Fox Run Management held 23,226 shares of Prelude Therapeutics worth $90.8K as of Q3 2026.
- Prelude Therapeutics was a new Fox Run Management position in Q3 2026.
- Prelude Therapeutics made up 0.01% of Fox Run Management's portfolio in Q3 2026, its #914 holding.
- 90 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.
Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.